Patent ID: 6303782
Filing Date: 2001-10-16
Classification: C07C,C07D

Abstract:
A process of preparing a tertiary-nitrile-substituted aromatic compound final product of Formula (1.0.0): ##STR43##comprising treating an aromatic compound of Formula (2.0.0): ##STR44##with a secondary nitrile of Formula (3.0.0): ##STR45##in the presence of a base having a pK.sub.a numerical value in the range of from about 17 to about 30, provided that the difference in pK.sub.a numerical values between said base and corresponding secondary nitrile of Formula (3.0.0) is not more than about 6; in an aprotic solvent having a dielectric constant (.di-elect cons.) of less than about 20; and at a reaction temperature in the range of from about 0.degree. C. to about 120.degree. C.; whereby there is formed said tertiary-nitrile-substituted aromatic compound final product of Formula (1.0.0);wherein the dashed lines, constituent parts W.sup.1, W.sup.2, W.sup.3, W.sup.4, and W.sup.5 ; and substituent moieties R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 wherever they appear in the above-recited compounds of Formulas (1.0.0), (2.0.0) and (3.0.0), all have the following meanings:(I) each of the dashed lines is independently absent or a bond, so that single or double bonds result at the respective positions of an aromatic compound of Formula (1.0.0) or (2.0.0), provided that at least one of said dashed lines is a bond;(II) W.sup.1, W.sup.2, W.sup.3, W.sup.4, and W.sup.5 is each C (carbon) and the dashed line associated therewith is a bond,(III) R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 is each independently selected so that when the corresponding W.sup.1-5 is C, said R.sup.1-5 is a member independently selected from the group consisting of hydrogen; halogen selected from Cl, Br, and I; --N(R.sup.12).sub.2 ; --SR.sup.12 ; --OR.sup.12 ; (C.sub.1 -C.sub.6) alkyl substituted with 0-3 R.sup.9, --N(R.sup.12).sub.2, --SR.sup.12, or --OR.sup.12 ; (C.sub.2 -C.sub.6) alkenyl substituted with 0-3 R.sup.9 ; (C.sub.3 -C.sub.6) alkynyl substituted with 0-3 R.sup.9 ; a (C.sub.3 -C.sub.14) carbocyclic ring system substituted with 0-3 R.sup.9 or 0-3 R.sup.10 ; a heterocyclic ring system independently selected from the group consisting of furanyl, thienyl, pyrrolyl, imidazolyl, pyridyl, pyrazolyl, pyrimidinyl, benzofuranyl, benzothienyl, indolyl, benzimidazolyl, tetrahydroisoquinolinyl, benzotriazolyl, and thiazolyl, said heterocyclic ring system being substituted with 0-2 R.sup.10 ; and any two R.sup.1-5 attached to adjacent carbon atoms taken together to form a 3- or 4-carbon chain forming a fused 5- or 6-membered ring, or a carbon-nitrogen-nitrogen chain forming an indazolyl fused ring, both of said rings being optionally substituted on any aliphatic carbon atoms thereof with a member selected from the group consisting of halogen selected from Cl, Br, and I; (C.sub.1 -C.sub.4) alkyl; (C.sub.1 -C.sub.4) alkoxy; and --NR.sup.15 R.sup.16 ; where:(A) R.sup.9 is a member independently selected from the group consisting of hydrogen; cyano; --CH.sub.2 NR.sup.15 R.sup.16 ; --NR.sup.15 R.sup.16 ; --R.sup.15 ; --OR.sup.15 ; (C.sub.2 -C.sub.6) alkenyl; (C.sub.3 -C.sub.7) cycloalkyl; (C.sub.3 -C.sub.6) cycloalkylmethyl; phenethyl; phenoxy; benzyloxy; (C.sub.3 -C.sub.6) cycloalkoxy, (C.sub.1 -C.sub.4) alkyl substituted by a member selected from the group consisting of methylenedioxy, ethylenedioxy, phenyl(C.sub.1 -C.sub.3) alkyl, and a (C.sub.5 -C.sub.14) carbocyclic residue; and a 5- to 10-membered heterocyclic ring system containing 1 to 4 heteroatoms independently selected from oxygen, nitrogen, and sulfur, substituted with 0 to 3 substituents R.sup.15 ; where:(1) R.sup.15 is a member selected from the group consisting of phenyl substituted by 0-3 R.sup.11 ; benzyl substituted by 0-3 R.sup.11 ; (C.sub.1 -C.sub.6) alkyl substituted by 0-3 R.sup.11 ; (C.sub.2 -C.sub.4) alkenyl substituted by 0-3 R.sup.11 ; and (C.sub.2 -C.sub.6) alkoxyalkyl substituted by 0-3 R.sup.11 ;where R.sup.11 is a member independently selected from the group consisting of cyano; --CH.sub.2 NR.sup.18 R.sup.19 ; --NR.sup.18 R.sup.19 ; (C.sub.3 -C.sub.6) alkoxyalkyl; (C.sub.1 -C.sub.4) alkyl; (C.sub.2 -C.sub.4) alkenyl; (C.sub.3 -C.sub.10) cycloalkyl; (C.sub.3 -C.sub.6) cycloalkylmethyl; benzyl; phenethyl; phenoxy; benzyloxy; (C.sub.7 -C.sub.10) arylalkyl; (C.sub.3 -C.sub.6) cycloalkoxy; methylenedioxy; ethylenedioxy; and a (C.sub.5 -C.sub.14) carbocyclic residue; and a 5- to 10-membered heterocyclic ring system containing 1 to 4 heteroatoms independently selected from oxygen, nitrogen, and sulfur;where R.sup.18 and R.sup.19 are each independently selected from the group consisting of (C.sub.1 -C.sub.6) alkyl; and phenyl substituted with 0-3 R.sup.11 ;(2) R.sup.16 is a member selected from the group consisting of (C.sub.1 -C.sub.4) alkyl substituted by 0-3 groups selected from the group consisting of (C.sub.1 -C.sub.4) alkoxy; (C.sub.2 -C.sub.6) alkoxyalkyl; (C.sub.2 -C.sub.6) alkenyl; phenyl; and benzyl;(B) R.sup.10 when a substituent on a carbon atom, is a member independently selected from the group consisting of phenyl; benzyl; phenethyl; phenoxy; benzyloxy; halogen; cyano; (C.sub.1 -C.sub.4) alkyl; (C.sub.3 -C.sub.7) cycloalkyl; (C.sub.3 -C.sub.6) cycloalkylmethyl; (C.sub.1 -C.sub.6) alkoxy; (C.sub.1 -C.sub.4) alkoxy(C.sub.1 -C.sub.3) alkyl; (C.sub.3 -C.sub.6) cycloalkoxy; (C.sub.1 -C.sub.6) alkylthio; (C.sub.1 -C.sub.4) alkylthio(C.sub.1 -C.sub.3) alkyl; --OR.sup.15 ; --NR.sup.15 R.sup.16 ; (C.sub.1 -C.sub.4) alkyl substituted by --NR.sup.15 R.sup.16 ; (C.sub.2 -C.sub.6) alkoxyalkylene optionally substituted by Si[(C.sub.1 -C.sub.3) alkyl].sub.3 ; methylenedioxy; ethylenedioxy; --S(O).sub.m R.sup.15 ; --SO.sub.2 NR.sup.15 R.sup.16 ; --OCH.sub.2 CO.sub.2 R.sup.15 ; --C(R.sup.16).dbd.N(OR.sup.16); and a 5- or 6-membered heterocyclic ring system containing from 1 to 4 heteroatoms selected from oxygen, nitrogen, and sulfur; orR.sup.10 when a substituent on a nitrogen atom, is a member independently selected from the group consisting of phenyl; benzyl; phenethyl; (C.sub.1 -C.sub.4) alkyl; (C.sub.1 -C.sub.4) alkoxy; (C.sub.3 -C.sub.6) cycloalkyl; (C.sub.3 -C.sub.6) cycloalkylmethyl; (C.sub.2 -C.sub.6) alkoxyalkyl; --CH.sub.2 NR.sup.15 R.sup.16 ; --NR.sup.15 R.sup.16 ; and --C(R.sup.16).dbd.N(OR.sup.16);where R.sup.15 and R.sup.16 have the same meaning as recited further above;(C) R.sup.12 is a member selected from the group consisting of (C.sub.1 -C.sub.6) alkyl substituted )y 0-3 R.sup.9 ; and (C.sub.3 -C.sub.6) alkoxyalkyl substituted by 0-3 R.sup.9 ; andwhere R.sup.9 has the same meaning as recited further above;(IV) R.sup.6 and R.sup.7 are each independently selected from the group consisting of (C.sub.1 -C.sub.6) alkyl substituted with 0-3 R.sup.9 ; --N(R.sup.12).sub.2 ; --SR.sup.12 ; --OR.sup.12 ; (C.sub.2 -C.sub.6) alkenyl substituted with 0-3 R.sup.9 ; (C.sub.3 -C.sub.6) alkynyl substituted with 0-3 R.sup.9 ; a (C.sub.3 -C.sub.14) carbocyclic ring system substituted with 0-3 R.sup.9 or 0-3 R.sup.10 ; and a heterocyclic ring system independently selected from the group consisting of furanyl, thienyl, pyrrolyl, imidazolyl, tetrahydropyranyl, pyridyl, piperidinyl, pyrazolyl, pyrimidinyl, benzofuranyl, benzothienyl, indolyl, benzimidazolyl, tetrahydroisoquinolinyl, benzotriazolyl, and thiazolyl, said heterocyclic ring system being substituted with 0-2 R.sup.10 ; orR.sup.6 and R.sup.7 are taken together to form a (C.sub.3 -C.sub.14) carbocyclic ring system substituted with 0-3 R.sup.9 or 0-3 R.sup.10 ; phenyl; 1- or 2-naphthyl substituted with 0-3 R.sup.9 or 0-3 R.sup.10 ; or a heterocyclic ring system independently selected from the group consisting of furanyl, thienyl, pyrrolyl, imidazolyl, tetrahydropyranyl, pyridyl, piperidinyl, pyrazolyl, pyrimidinyl, benzofuranyl, benzothienyl, indolyl, benzimidazolyl, tetrahydroisoquinolinyl, benzotriazolyl, and thiazolyl, said heterocyclic ring system being substituted with 0-2 R.sup.10 ; where:R.sup.9, R.sup.10, R.sup.12, R.sup.15 and R.sup.16 each have the same meaning as set out further above under the definitions of R.sup.1-5.